SCHEMBL8267151

SCHEMBL8267151

COc1ccc2c(c1)CN(c1cnnc3cc(OC)c(C(C)O)cc13)CC2

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.40
PDE10A Q9Y233 1/20 0.39
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
DRD1 P21728 2/20 0.35
DRD2 P14416 1/20 0.35
DRD5 P21918 1/20 0.35
TIPARP Q7Z3E1 2/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
PRMT5 O14744 3/20 0.35
WDR77 Q9BQA1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8266921 0.91 PDGFRB (0.50) PDGFRBPDE10AALDH1A1MAPTPRMT5
SCHEMBL8267024 0.91 PDE10A (0.39) PDGFRBPDE10AADRA1DADRA1AADRA1B
SCHEMBL8266829 0.90 TIPARP (0.39) PDGFRBPDE10AMAPTTIPARPPRMT5
SCHEMBL5287072 0.88 PDGFRB (0.47) PDGFRBPDE10AKDM4EALDH1A1MAPT
SCHEMBL8266928 0.88 PDGFRB (0.41) PDGFRBPDE10ADRD1
SCHEMBL8265806 0.87 TRPV3 (0.38) PDGFRBPDE10AMAPTADRA1DADRA1A
SCHEMBL8266918 0.87 PDGFRB (0.39) PDGFRBPDE10AADRA1DADRA1AADRA1B
SCHEMBL8265764 0.87 PDE10A (0.39) PDGFRBPDE10AADRA1DADRA1AADRA1B
SCHEMBL5301608 0.84 PDGFRB (0.47) PDGFRBPDE10AMAPTDRD1DRD2
SCHEMBL8267157 0.83 PDE10A (0.41) PDGFRBPDE10ATIPARPPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006028957-A1 4-SUBSTITUTED 4, 6-DIALKOXY-CINNOLINE DERIVATIVES AS PHOSPODIESTERASE 10 INHIBITORS FOR THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL SYNDROMS MEMORY PHARMACEUTICALS CORPORATION (US) 2006-03-16 WO disclosed